or Try an Advanced Search...

    Technical Analysis for PHGE - BiomX Inc.

    Grade Last Price % Change Price Change
    D 0.30 5.61% 0.02
    PHGE closed up 5.61 percent on Thursday, April 18, 2024, on 4 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 10
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical PHGE trend table...
    Date Alert Name Type % Chg
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    50 DMA Resistance Bearish 5.61%
    Stochastic Buy Signal Bullish 5.61%
    Wide Bands Range Expansion 5.61%
    Down 3 Days in a Row Weakness 5.61%
    Down 4 Days in a Row Weakness 5.61%
    Down 5 Days in a Row Weakness 5.61%
    Oversold Stochastic Weakness 5.61%
    Older End-of-Day Signals for PHGE ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    Possible Inside Day about 18 hours ago
    Up 5% about 22 hours ago
    Up 3% about 22 hours ago
    Up 2% about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PHGE Chart by TradingView
    Basic chart:

    Profile

    BiomX Inc., a clinical-stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from dysbiosis of the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases, primary sclerosing cholangitis, and cancer. The company is based in Ness Ziona, Israel.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Medicine Cancer Clinical Medicine Disease Autoimmune Disease Inflammatory Bowel Disease Chronic Disease Hepatology Digestive System Primary Sclerosing Cholangitis Bacteriophage

    Is PHGE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 18 BiomX Announces the Appointment of Susan Blum to its Board of Directors
    Apr 5 Here's Why BiomX (PHGE) Is a Great 'Buy the Bottom' Stock Now
    Apr 4 BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
    Apr 3 BiomX Inc. (PHGE) Q4 2023 Earnings Call Transcript
    Apr 3 BiomX GAAP EPS of -$0.51
    Apr 3 BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    Mar 27 BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024
    Mar 18 BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
    Mar 6 Why BiomX Stock Is Surging Today
    Mar 6 BiomX surges on merger deal with Adaptive Phage
    See more PHGE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.855
    52 Week Low 0.1866
    Average Volume 3,238,259
    200-Day Moving Average 0.33
    50-Day Moving Average 0.31
    20-Day Moving Average 0.35
    10-Day Moving Average 0.32
    Average True Range 0.05
    RSI (14) 43.50
    ADX 27.21
    +DI 23.54
    -DI 19.39
    Chandelier Exit (Long, 3 ATRs) 0.32
    Chandelier Exit (Short, 3 ATRs) 0.41
    Upper Bollinger Bands 0.43
    Lower Bollinger Band 0.26
    Percent B (%b) 0.19
    BandWidth 47.59
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0127
    Fundamentals Value
    Market Cap 13.6 Million
    Num Shares 46 Million
    EPS -0.63
    Price-to-Earnings (P/E) Ratio -0.47
    Price-to-Sales 0.00
    Price-to-Book 1.27
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.34
    Resistance 3 (R3) 0.34 0.33 0.33
    Resistance 2 (R2) 0.33 0.31 0.33 0.33
    Resistance 1 (R1) 0.31 0.31 0.32 0.31 0.33
    Pivot Point 0.29 0.29 0.30 0.30 0.29
    Support 1 (S1) 0.28 0.28 0.29 0.28 0.26
    Support 2 (S2) 0.26 0.28 0.26 0.26
    Support 3 (S3) 0.25 0.26 0.26
    Support 4 (S4) 0.25